Dikla Berko, Ph.D.

Affiliations: 
2010 Weizmann Institute of Science, Rehovot, Israel 
Area:
Cell Biology
Google:
"Dikla Berko"
Mean distance: (not calculated yet)
 

Parents

Sign in to add mentor
Ami Navon grad student 2010 Weizmann Institute
 (Insights into the Mechanism of Proteasomal Degradation.)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Tabachnick-Cherny S, Pinto S, Berko D, et al. (2020) Polyglutamine-Related Aggregates Can Serve as a Potent Antigen Source for Cross-Presentation by Dendritic Cells. Journal of Immunology (Baltimore, Md. : 1950)
Demishtein A, Fraiberg M, Berko D, et al. (2017) SQSTM1/p62-mediated autophagy compensates for loss of proteasome polyubiquitin recruiting capacity. Autophagy. 0
Berko D, Herkon O, Braunstein I, et al. (2014) Inherent asymmetry in the 26S proteasome is defined by the ubiquitin receptor RPN13. The Journal of Biological Chemistry. 289: 5609-18
Berko D, Tabachnick-Cherny S, Shental-Bechor D, et al. (2012) The direction of protein entry into the proteasome determines the variety of products and depends on the force needed to unfold its two termini. Molecular Cell. 48: 601-11
Margalit A, Sheikhet HM, Carmi Y, et al. (2006) Induction of antitumor immunity by CTL epitopes genetically linked to membrane-anchored beta2-microglobulin. Journal of Immunology (Baltimore, Md. : 1950). 176: 217-24
Berko D, Carmi Y, Cafri G, et al. (2005) Membrane-anchored beta 2-microglobulin stabilizes a highly receptive state of MHC class I molecules. Journal of Immunology (Baltimore, Md. : 1950). 174: 2116-23
Margalit A, Fishman S, Berko D, et al. (2003) Chimeric beta2 microglobulin/CD3zeta polypeptides expressed in T cells convert MHC class I peptide ligands into T cell activation receptors: a potential tool for specific targeting of pathogenic CD8(+) T cells. International Immunology. 15: 1379-87
See more...